Search

Your search keyword '"Choi, Yoon Seok"' showing total 844 results

Search Constraints

Start Over You searched for: Author "Choi, Yoon Seok" Remove constraint Author: "Choi, Yoon Seok"
844 results on '"Choi, Yoon Seok"'

Search Results

3. Safety and efficacy of a novel anti-CD19 chimeric antigen receptor T cell product targeting a membrane-proximal domain of CD19 with fast on- and off-rates against non-Hodgkin lymphoma: a first-in-human study

8. Follow-up on phase 1 study of AT101, a novel anti-CD19 chimeric antigen receptor cell therapy (CAR-T) in patients with relapsed or refractory (r/r) b-cell non-Hodgkin lymphoma.

16. Geriatric risk model for older patients with diffuse large B-cell lymphoma (GERIAD): a prospective multicenter cohort study

18. A phase II study of ibrutinib in combination with rituximab-cyclophosphamide-doxorubicin hydrochloride-vincristine sulfate-prednisone therapy in Epstein-Barr virus-positive, diffuse large B cell lymphoma (54179060LYM2003: IVORY study): results of the final analysis

24. P-431 Clinical characteristics, prognostic factors and treatment outcomes in patients diagnosed with primary plasma cell leukemia based on the revised criteria (KMM2204)

25. The comprehensive expression of BCL2 family genes determines the prognosis of diffuse large B-cell lymphoma

27. Correction to: Priorities of a “good death” according to cancer patients, their family caregivers, physicians, and the general population: a nationwide survey

29. A risk stratification model for nodal peripheral T-cell lymphomas based on the NCCN-IPI and posttreatment Deauville score

30. Comparison of first-line treatment with CHOP versus ICED in patients with peripheral T-cell lymphoma eligible for upfront autologous stem cell transplantation

34. Priorities of a “good death” according to cancer patients, their family caregivers, physicians, and the general population: a nationwide survey

37. The comprehensive expression of BCL2 family genes determines the prognosis of diffuse large B-cell lymphoma]{The comprehensive expression of BCL2 family genes determines the prognosis of diffuse large B-cell lymphoma

39. Supplementary Table S2 from PD-1 Blockade Reinvigorates Bone Marrow CD8+ T Cells from Patients with Multiple Myeloma in the Presence of TGFβ Inhibitors

40. Supplementary Data from PD-1 Blockade Reinvigorates Bone Marrow CD8+ T Cells from Patients with Multiple Myeloma in the Presence of TGFβ Inhibitors

43. Supplementary Figures S1-S21 from PD-1 Blockade Reinvigorates Bone Marrow CD8+ T Cells from Patients with Multiple Myeloma in the Presence of TGFβ Inhibitors

45. A non-interventional, post-marketing surveillance study evaluating the safety and effectiveness of biosimilar rituximab (CT-P10) during routine clinical practice in the Republic of Korea

47. Phase II study of bortezomib, cytarabine and dexamethasone in relapsed or refractory mantle cell lymphoma.

48. C-C Motif Chemokine Receptor 3-Mediated Extracellular Signal-Regulated Kinase 1/2 and p38 Mitogen-Activated Protein Kinase Signaling: Promising Targets for Human Airway Epithelial Mucin 5AC Induction by Eotaxin-2 and Eotaxin-3.

49. Outcomes in Refractory Diffuse Large B-Cell Lymphoma: Results from Two Prospective Korean Cohorts

Catalog

Books, media, physical & digital resources